(Q45834675)

16 December 2017

title

Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction (English)

1 reference

16 December 2017

0 references

1

1 reference

16 December 2017

Sigurbjörg Torsteinsdóttir

0 references

author name string

Szigeti R

2

1 reference

16 December 2017

Ernberg I

3

1 reference

16 December 2017

Hu CP

4

1 reference

16 December 2017

Torsteinsdottir S

5

1 reference

16 December 2017

Frade R

6

1 reference

16 December 2017

Klein E

7

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 June 1987

1 reference

16 December 2017

European Journal of Immunology

published in

1 reference

16 December 2017

volume

17

1 reference

16 December 2017

page(s)

815-820

1 reference

16 December 2017

issue

6

1 reference

16 December 2017

Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein–Barr virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Epstein-Barr virus superinduces a new human b cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

A second nuclear protein is encoded by Epstein-Barr virus in latent infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Early events in Epstein-Barr virus infection provide a model for B cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

B cell activation by the nontransforming P3HR-1 substrain of the Epstein-Barr virus (EBV).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Production of leukocyte migration inhibitory factor (LIF) in human lymphocyte subsets exposed to polyclonal activators

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Mediators of Immunity: Lymphokines and Monokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Leukocyte migration inhibitory factor production by activated lymphocytes representing immunological memory or virus-receptor interaction: response of T cell subsets to Epstein-Barr virus nuclear antigen, response of B cells to UV inactivated Epstei

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp 140 molecule

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Growth control of activated, synchronized murine B cells by the C3d fragment of human complement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Release of infectious Epstein-Barr virus by transformed marmoset leukocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Ultraviolet inactivation of Epstein--Barr virus-induced nuclear antigen (EBNA), DNA and IgM synthesis in human B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Comparison of highly NK active human lymphocyte subsets separated by various procedures involving E, EA rosetting, density gradients and adherence to immune complexes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Epstein-Barr virus susceptibility of normal human B lymphocyte populations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Requirement for macrophages or for macrophage- or T cell-derived factors in the mitogenic stimulation of murine B lymphocytes by lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Stimulation of murine B cells with anti-Ig antibodies: dominance of a negative signal mediated by the Fc receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulated with phytohemagglutinin. I. Effect of various metabolic inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Relationship between RNA content and progression of lymphocytes through S phase of cell cycle

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Sorting of B lymphoblasts based upon cell diameter provides cell populations enriched in different stages of cell cycle

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

B-cell stimulatory factor 1 activates resting B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Biological differences between epstein-barr virus (EBV) strains with regard to lymphocyte transforming ability, superinfection and antigen induction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830170613

7 January 2021

Identifiers

DOI

10.1002/EJI.1830170613

1 reference

16 December 2017

PubMed ID

3036539

1 reference

16 December 2017